List view / Grid view

sarilumab

Filter the results

 

news

Sanofi and Regeneron announce EMA acceptance for review of Marketing Authorisation Application for sarilumab

1 August 2016 | By Sanofi / Regeneron Pharmaceuticals, Inc.

Sanofi and Regeneron Pharmaceuticals, Inc. have announced that the European Medicines Agency has accepted for review the Marketing Authorisation Application for sarilumab, an investigational human monoclonal antibody directed against the IL-6 receptor that is intended for the treatment of adult patients with moderately to severely active rheumatoid arthritis...